ChromaDex price target raised to $8.10 from $6.80 at Ladenburg

Ladenburg analyst Jeffrey Cohen raised the firm’s price target on ChromaDex (CDXC) to $8.10 from $6.80 and keeps a Buy rating on the shares following the Q4 report. The company is undergoing a rebranding to better align with its evolving strategic efforts, the analyst tells investors in a research note.